Christopher J Cates

Summary

Affiliation: St George's
Country: UK

Publications

  1. doi request reprint Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children
    Christopher J Cates
    Population Health Sciences and Education, St George s, University of London, London, UK
    Cochrane Database Syst Rev 4:CD007313. 2013
  2. doi request reprint Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews
    Christopher J Cates
    Population Health Sciences and Education, St George s, University of London, London, UK
    Cochrane Database Syst Rev 10:CD010005. 2012
  3. ncbi request reprint Regular treatment with formoterol for chronic asthma: serious adverse events
    Christopher J Cates
    Population Health Sciences and Education, St George s, University of London, London, UK
    Cochrane Database Syst Rev 4:CD006923. 2012
  4. doi request reprint Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events
    Christopher J Cates
    Population Health Sciences and Education, St George s, University of London, London, UK
    Cochrane Database Syst Rev 3:CD006922. 2013
  5. doi request reprint Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events
    Christopher J Cates
    Population Health Sciences and Education, St George s University of London, Cranmer Terrace, London, UK, SW17 0RE
    Cochrane Database Syst Rev 6:CD006924. 2013
  6. ncbi request reprint Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events
    Christopher J Cates
    Population Health Sciences and Education, St George s, University of London, Cranmer Terrace, London, UK, SW17 0RE
    Cochrane Database Syst Rev 3:CD007695. 2012
  7. doi request reprint Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease
    Charlotta Karner
    Population Health Sciences and Education, St George s, University of London, London, UK
    Cochrane Database Syst Rev 4:CD008989. 2012
  8. doi request reprint Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma
    Christopher J Cates
    Population Health Sciences and Education, St George s University of London, Cranmer Terrace, London, UK, SW17 0RE
    Cochrane Database Syst Rev 9:CD000052. 2013
  9. doi request reprint Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease
    Emma J Welsh
    Population Health Sciences and Education, St George s University of London, London, UK
    Cochrane Database Syst Rev 5:CD007891. 2013
  10. doi request reprint Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews
    Christopher J Cates
    Population Health Research Institute, St George s, University of London, Cranmer Terrace, London, UK, SW17 0RE
    Cochrane Database Syst Rev 2:CD010314. 2014

Detail Information

Publications15

  1. doi request reprint Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children
    Christopher J Cates
    Population Health Sciences and Education, St George s, University of London, London, UK
    Cochrane Database Syst Rev 4:CD007313. 2013
    ..The combination of formoterol and budesonide in one inhaler has made possible a single inhaler for both prevention and relief of symptoms (single inhaler therapy or SiT)...
  2. doi request reprint Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews
    Christopher J Cates
    Population Health Sciences and Education, St George s, University of London, London, UK
    Cochrane Database Syst Rev 10:CD010005. 2012
    ..No similar sized surveillance studies have been carried out in children with asthma, and we remain uncertain about the comparative safety of regular combination therapy with either formoterol or salmeterol in children with asthma...
  3. ncbi request reprint Regular treatment with formoterol for chronic asthma: serious adverse events
    Christopher J Cates
    Population Health Sciences and Education, St George s, University of London, London, UK
    Cochrane Database Syst Rev 4:CD006923. 2012
    ..There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe...
  4. doi request reprint Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events
    Christopher J Cates
    Population Health Sciences and Education, St George s, University of London, London, UK
    Cochrane Database Syst Rev 3:CD006922. 2013
    ..There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are safe. This is an updated systematic review...
  5. doi request reprint Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events
    Christopher J Cates
    Population Health Sciences and Education, St George s University of London, Cranmer Terrace, London, UK, SW17 0RE
    Cochrane Database Syst Rev 6:CD006924. 2013
    ..Much debate has surrounded possible causal links for this association and whether regular (daily) long-acting beta2-agonists are safe when used alone or in conjunction with inhaled corticosteroids. This is an updated Cochrane Review...
  6. ncbi request reprint Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events
    Christopher J Cates
    Population Health Sciences and Education, St George s, University of London, Cranmer Terrace, London, UK, SW17 0RE
    Cochrane Database Syst Rev 3:CD007695. 2012
    ..An increase in serious adverse events with both regular formoterol and regular salmeterol in chronic asthma has been demonstrated in previous Cochrane reviews...
  7. doi request reprint Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease
    Charlotta Karner
    Population Health Sciences and Education, St George s, University of London, London, UK
    Cochrane Database Syst Rev 4:CD008989. 2012
    ..However, the benefits and risks of combining tiotropium and long-acting beta(2)-agonists for the treatment of chronic obstructive pulmonary (COPD) disease are unclear...
  8. doi request reprint Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma
    Christopher J Cates
    Population Health Sciences and Education, St George s University of London, Cranmer Terrace, London, UK, SW17 0RE
    Cochrane Database Syst Rev 9:CD000052. 2013
    ..Nebulisers require a power source and need regular maintenance, and are more expensive in the community setting...
  9. doi request reprint Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease
    Emma J Welsh
    Population Health Sciences and Education, St George s University of London, London, UK
    Cochrane Database Syst Rev 5:CD007891. 2013
    ..There is uncertainty about the relative benefits and harms of these treatments...
  10. doi request reprint Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews
    Christopher J Cates
    Population Health Research Institute, St George s, University of London, Cranmer Terrace, London, UK, SW17 0RE
    Cochrane Database Syst Rev 2:CD010314. 2014
    ..Clinical trials record these safety outcomes as non-fatal and fatal serious adverse events (SAEs), respectively...
  11. ncbi request reprint The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease
    Charlotta Karner
    Population Health Sciences and Education, St George s, University of London, London, UK
    Cochrane Database Syst Rev 9:CD009039. 2011
    ..However, the benefits and risks of adding inhaled corticosteroid to tiotropium and long-acting beta(2)-agonists for the treatment of chronic obstructive pulmonary disease are unclear...
  12. ncbi request reprint Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis
    Kayleigh M Kew
    Population Health Research Institute, St George s, University of London, Cranmer Terrace, London, UK, SW17 0RE
    Cochrane Database Syst Rev 3:CD010844. 2014
    ..However for patients and clinicians, it is important to understand the merits of these treatments relative to each other, and whether a particular class of inhaled therapies is more beneficial than the others...
  13. ncbi request reprint Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
    Charlotta Karner
    Population Health Sciences and Education, St George s, University of London, London, UK
    Cochrane Database Syst Rev 3:CD008532. 2011
    ..However, the benefits and risks of using tiotropium and combination therapy together for the treatment of chronic obstructive pulmonary disease are unclear...
  14. doi request reprint Vaccines for preventing influenza in people with asthma
    Christopher J Cates
    Population Health Sciences and Education, St George s, University of London, London
    Cochrane Database Syst Rev 2:CD000364. 2013
    ..While an overview concluded that there was no clear benefit of influenza vaccination in patients with asthma, this conclusion was not based on a systematic search of the literature...
  15. doi request reprint Bronchodilator treatment and asthma death: a new analysis of a British case-control study
    Barbara K Butland
    Division of Population Health Sciences and Education, St George s, University of London, Cranmer Terrace, Tooting, London SW17 ORE, UK
    Respir Med 105:549-57. 2011
    ..In a population based case-control study where prescription of LABA without concomitant ICS was uncommon there was no evidence of an overall association between LABA and asthma death...